Novel Agent Lessens Mucositis in Head and Neck Cancers
(MedPage Today) -- CHICAGO – Severe oral mucositis among patients undergoing radiation and platinum-based chemotherapy for locally-advanced head and neck cancers can be significantly reduced by the novel agent avasopasem manganese, researchers...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Head and Neck Cancer | Hematology | Manganese | Oral Cancer